Retina specialists have a lot of options when it comes to intravitreal injection procedures, according to a speaker at Retina ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

Timothy Eugene Sullivan, the Chief Financial Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold 3,088 ...

Kura Oncology's stock plummeted 50% after announcing a collaboration with Kyowa Kirin, making it a less attractive ...

Analog Devices, Inc. (NASDAQ: ADI) today announced the appointment of Andrea F. Wainer, a seasoned healthcare executive, to ...

Pascal Deschatelets, the Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently executed a stock transaction involving the sale of company shares. According to a filing with ...

In a report released today, Miki Sogi from Bernstein maintained a Buy rating on Astellas Pharma (ALPMF – Research Report), with a price target ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...